[April 04, 2014] |
 |
Research and Markets: European Endocrine Function Testing Market 2014: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/7z5zdd/european)
has announced the addition of the "European
Endocrine Function Testing Market 2014: Hospitals, Commercial Labs,
Physician Offices, Ambulatory Care Centers" report to their
offering.
European Endocrine Function Testing Market 2014: Hospitals, Commercial
Labs, Physician Offices, Ambulatory Care Centers is a unique market and
technology assessment designed to help current suppliers and potential
market entrants idenify and evaluate emerging opportunities and
developed effective strategic responses. The study explores future
trends; provides test volume and sales forecasts; compares features of
leading analyzers; and profiles key competitors.
The report provides test volume and sales forecasts by country and
market segment for the following assays: Cortisol, Estradiol, FSH, HCG,
Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free
T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH.
During the next five years, the endocrine function testing market will
undergo significant transformation. These changes will be caused by
convergence of new and more stringent regulations; advances in
diagnostic technologies, system engineering, automation, and IT; and
intensifying competition. Some segments will start resembling commodity
markets, where product positioning and cost per test are more critical
than underlying technology. This evolving marketplace will create
exciting opportunities for a variety of new instruments, reagent
systems, and auxiliary products, such as specimen preparation devices,
controls, calibrators and others.
For more information visit http://www.researchandmarkets.com/research/7z5zdd/european

[ Back To TMCnet.com's Homepage ]
|